A Multicenter Trial of YSQTG Combined With Immuno-chemotherapy for Extensive-Stage Small Cell Lung Cancer

​ Conditions: Extensive-stage Small Cell Lung Cancer (SCLC)

Interventions: Drug: Yishen Qutong Granules; Drug: Yishen Qutong Simulant Granules

Sponsors: LI FENG; Henan Cancer Hospital; Fudan University; Shanxi Province Cancer Hospital

Enrolling by invitation Conditions: Extensive-stage Small Cell Lung Cancer (SCLC)
Interventions: Drug: Yishen Qutong Granules; Drug: Yishen Qutong Simulant Granules
Sponsors: LI FENG; Henan Cancer Hospital; Fudan University; Shanxi Province Cancer Hospital
Enrolling by invitation